Sort
8,912 grants matching “sars cov 2”
Assessment of Zoonotic Risk of Emerging Infections in Companion Animals
$218,870Laura Brunengraber Goodman · Cornell University · U18 · FY2022 · FD
How S. aureus protein SSL11 inhibits neutrophil migration
$218,865Chen Chen · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2022 · GM
T cell modulation of COVID-19 disease
$218,750Nicholas James Maness · Tulane University Of Louisiana · R21 · FY2022 · AI
Alphavirus Vectored Vaccines for the SARS Coronavirus
$218,610University Of North Carolina Chapel Hill · P01 · FY2005 · AI
Salivary gland response to innate immune mediators dictates Sjogren's syndrome development
$218,500Umesh S Deshmukh · Oklahoma Medical Research Foundation · R21 · FY2022 · DE
SBIR Phase I: Assessing Risk of COVID-19 Infection with Cell Mediated Immunity
$218,396Chethan Ashokkumar · Plexision, Inc. · · FY2020 · TIP
Rewiring SARS-CoV Genome Organization and Pathogenesis
$218,242University Of North Carolina Chapel Hill · P01 · FY2005 · AI
Rapid antibody screening systems to identify and engineer antiviral protection
$218,229Brandon James Dekosky · Massachusetts General Hospital · R21 · FY2023 · AI
Informatics Approach to Identification and Deep Phenotyping of PASC Cases
$217,865Xiaoming Li · University Of South Carolina At Columbia · R21 · FY2022 · AI
Immunity to SARS-CoV-2 After Natural Infection or Vaccination
$217,764Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Deciphering the role of chemical signals in inflammation with open microfluidic functional assays
$217,700Ashleigh Brooks Theberge · University Of Washington · R35 · FY2022 · GM
Palliative Care Research Cooperative Group (PCRC): Refinement and Expansion
$217,698Jean S Kutner · University Of Colorado Denver · U2C · FY2021 · NR
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
$217,604Koen K Van Rompay · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
Molecular Biology of Viral Diseases
$217,529Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · T32 · FY2009 · AI
CRST COVID-19 - Wayakta He
$217,464Esther Erdei · University Of New Mexico Health Scis Ctr · R21 · FY2021 · ES
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
$217,459Christopher F Basler · Icahn School Of Medicine At Mount Sinai · R21 · FY2022 · AI
Entry inhibition of SARS-CoV-2 by human LRRC15
$217,338Sanghyun Lee · Brown University · R21 · FY2023 · AI
Elucidating the role of the SARS-CoV-2 ORF9b protein in virus replication
$217,337Mohsan Saeed · Boston University Medical Campus · R21 · FY2025 · AI
Chimeric ACE2 peptide ligand for diagnostic assays of SARS-CoV-2
$217,282Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
The AnVIL Data Ecosystem
$217,232Anthony Philippakis · Broad Institute, Inc. · U24 · FY2020 · HG
Mobile Health Study and Chemoprophylaxis for Preventing Severe Illness from COVID-19 in Cancer
$217,000Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2020 · CA
Immune phenotyping of responses to influenza virus vaccination and infection
$216,944Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
Deciphering the role of chemical signals in inflammation with open microfluidic functional assays - U3 Supplement
$216,736Ashleigh Brooks Theberge · University Of Washington · R35 · FY2024 · GM
Core C: Clinical and Biostatistic Core
$216,428Srilatha Edupuganti · Emory University · U19 · FY2020 · AI
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes
$216,250Leigh Meredith Howard · Vanderbilt University Medical Center · R21 · FY2023 · AI